Recall Register

Clark Laboratories, Inc. (dba,Trinity Biotech USA): FDA recalls

Newest recall start date in this list: . ultra2 Genesys Variants Analyzer, REF 03-01-0045 intended to be used with automated high performance liquid chromatography (HPLC) systems…

FDA enforcement events from 2012 to 2018; export dated . The recall start date and FDA report date are separate fields. Read the recall classes.

FDA enforcement reports name Clark Laboratories, Inc. (dba,Trinity Biotech USA) as the recalling firm in 5 events. The events have 9 product records. The recalls started from 2012 to 2018. All the events are device recalls. By FDA enforcement events, Clark Laboratories, Inc. (dba,Trinity Biotech USA) is number 679 of 1,629 firms that have a page. Events that Clark Laboratories, Inc. (dba,Trinity Biotech USA) started: none in 2024 and none in 2025. For all FDA enforcement events, the count rose by 3.6%, from 1,773 in 2024 to 1,836 in 2025. Class III is 60.0% of its events and 8.6% of all FDA events.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Enforcement events

5 events, newest first.

FDA enforcement events of Clark Laboratories, Inc. (dba,Trinity Biotech USA)
InitiatedProduct (first record)TypeClassRecordsStatus
1 Nov 2018ultra2 Genesys Variants Analyzer, REF 03-01-0045 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange chromatography. For in vitro diagnostic use only.DeviceClass II5Terminated
11 Jul 2016Trinity Biotech Captia Measles IgM, REF/Product Code 2326060,Test Kit for 96 Determinations, IVDDeviceClass III1Terminated
17 Nov 2014Trinity biotech Captia (TM) Syphilis IgM Capture Test Kit, Product No./REF 800-935, Test Kit for 96 Determinations, IVD for In Vitro Diagnostic use; an antibody class capture enzyme immunoassay for the detection of IgM antibodies to T. pallidum as an aid to the identification of active syphilis in human serum.DeviceClass III1Terminated
27 Aug 2013Captia Syphilis-G Test Kit Product Usage: This is an enzyme immunoassay for the qualitative detection of IgG antibodies to T. pallidum in serum specimens, to be used in conjunction with non-treponemal testing to provide serological evidence of infection with T. pallidum ( the agent of syphilis). It is also intended…DeviceClass II1Terminated
29 May 2012Trinity Biotech, Captia VZV IgG. Product code 2325600: 96 Tests; product code: 2325601: 480 tests. For in vitro diagnostic use. Intended for the detection and quantitative determination of IgG antibody to VZV in human sera.DeviceClass III1Terminated

An event with 1 product record and a class that is not Class I has no page. It has a row in this table.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Recalling firm: The firm that the FDA record names for a recall.

Type and class

Clark Laboratories, Inc. (dba,Trinity Biotech USA): events for each product type
TypeEvents
Device5
Clark Laboratories, Inc. (dba,Trinity Biotech USA): events in each class
ClassEvents
Class III3
Class II2
Share of the events of the firm in Class I
0%
Share of all events on the register in Class I
18%
Events with the status Ongoing
0

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Events by year

FDA enforcement events of Clark Laboratories, Inc. (dba,Trinity Biotech USA), by the year that the recall started. The largest year is 2012, with 1 event.

Official channels

Cite this page

Recall Register. Clark Laboratories, Inc. (dba,Trinity Biotech USA): FDA recalls. https://recallregister.com/firm/clark-laboratories-inc-dba-trinity-biotech-usa/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
State of the firm address
NY

The firm name is the spelling in the FDA records. A company with 2 spellings has 2 pages.

A firm with more products can have more recalls. This site does not rate one firm against another. How the register is made. Report an error.

Questions

Which classes do the FDA recalls of Clark Laboratories, Inc. (dba,Trinity Biotech USA) have?
Class III: 3 events. Class II: 2 events. The class is for the product of a recall. It is not a class of the firm.
What is the newest FDA recall of Clark Laboratories, Inc. (dba,Trinity Biotech USA)?
FDA event 81488, which the firm started on 1 Nov 2018. The first product in the record is: ultra2 Genesys Variants Analyzer, REF 03-01-0045 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange chromatography. For in vitro diagnostic use only.
How many FDA recalls of Clark Laboratories, Inc. (dba,Trinity Biotech USA) have the status Ongoing?
No event has the status Ongoing in the openFDA file. openFDA says about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.